Guardian Pharmacy Services (GRDN)
Dispenses and manages medications for assisted living, behavioral health, and other long-term care facilities.
$43.65
vs last close−1.02 (−2.28%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 263 | 281 | 275 | 300 | 314 | 339 | 329 | 344 | 377 | 398 | 337 | 352 |
| Cost of revenue | 211 | 226 | 220 | 239 | 254 | 271 | 265 | 276 | 303 | 312 | 260 | 272 |
| Gross profit | 52 | 55 | 55 | 61 | 61 | 67 | 64 | 68 | 75 | 86 | 76 | 80 |
| 59 | 39 | 47 | 44 | 165 | 50 | 51 | 56 | 58 | 49 | 59 | 59 | |
| Selling, general & administrative | 59 | 39 | 47 | 44 | 165 | 50 | 51 | 56 | 58 | 49 | 59 | 59 |
| Operating income | −6 | 16 | 8 | 17 | −105 | 17 | 13 | 13 | 17 | 37 | 18 | 21 |
| −1 | −1 | −1 | −1 | −1 | −1 | 0 | 0 | 0 | −5 | 1 | 9 | |
| Interest expense | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | −1 | −9 |
| Income before tax | −7 | 15 | 7 | 16 | −106 | 16 | 13 | 13 | 17 | 31 | 18 | 30 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 4 | 4 | 4 | 7 | 10 | 5 | 8 |
| Net income from continuing operations | −7 | 15 | 7 | 16 | −106 | 12 | 9 | 9 | 10 | 21 | 14 | 22 |
| Net income | −11 | 12 | 3 | 11 | −113 | 12 | 9 | 9 | 10 | 21 | 13 | 22 |
| EPS, basic | −$0.19 | $0.38 | −$0.14 | $0.17 | −$2.00 | $0.20 | $0.15 | $0.15 | $0.16 | $0.33 | $0.21 | $0.35 |
| EPS, diluted | −$0.19 | $0.38 | −$0.14 | $0.17 | −$2.00 | $0.20 | $0.15 | $0.14 | $0.15 | $0.33 | $0.21 | $0.34 |
| Weighted average shares, basic | 61 | 61 | 61 | 61 | 61 | 61 | 62 | 62 | 62 | 63 | 63 | 63 |
| Weighted average shares, diluted | 61 | 61 | 61 | 61 | 61 | 61 | 63 | 63 | 63 | 64 | 64 | 64 |
| EBITDA | −2 | 20 | 13 | 22 | −100 | 22 | 19 | 18 | 23 | 37 | 24 | 30 |
| Depreciation & amortization | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 0 |
| EBIT | −6 | 15 | 8 | 17 | −105 | 17 | 13 | 13 | 17 | 31 | 18 | 30 |